Mendonça B S, Ferreira C A, Maia R C, Nestal de Moraes G
Laboratório de Hemato-Oncologia Celular e Molecular; Programa de Hemato-Oncologia Molecular, Instituto Nacional de Câncer (INCA), Praça da Cruz Vermelha, 23, 6° andar, Code: 20 230 130, Rio de Janeiro, Brazil.
Instituto de Bioquímica Médica Leopoldo de Meis, Universidade Federal do Rio de Janeiro (UFRJ), Avenida Carlos Chagas Filho, 373, 2° andar, room H2-003, Cidade Universitária, Code: 21 941 599, Rio de Janeiro, RJ, Brazil.
BBA Adv. 2022 Mar 20;2:100050. doi: 10.1016/j.bbadva.2022.100050. eCollection 2022.
X-linked inhibitor of apoptosis protein (XIAP) finely tunes the balance between survival and death to control homeostasis. XIAP is found aberrantly expressed in cancer, which has been shown to promote resistance to therapy-induced apoptosis and confer poor outcome. Despite its predominant cytoplasmic localization in human tissues, growing evidence implicates the expression of XIAP in other subcellular compartments in sustaining cancer hallmarks. Herein, we review our current knowledge on the prognostic role of XIAP localization and discuss molecular mechanisms underlying differential biological functions played in each compartment. The comprehension of XIAP subcellular shuttling and functional dynamics might provide the rationale for future anticancer therapeutics.
X连锁凋亡抑制蛋白(XIAP)精确调节生存与死亡之间的平衡以控制体内平衡。XIAP在癌症中呈异常表达,已证明其可促进对治疗诱导的凋亡的抗性并导致不良预后。尽管XIAP在人体组织中主要定位于细胞质,但越来越多的证据表明,XIAP在其他亚细胞区室中的表达有助于维持癌症特征。在此,我们综述了目前关于XIAP定位的预后作用的知识,并讨论了其在每个区室中发挥不同生物学功能的潜在分子机制。对XIAP亚细胞穿梭和功能动态的理解可能为未来的抗癌治疗提供理论依据。